Context Therapeutics EPS Basic from Accounting Change (Quarterly) Trends

Context Therapeutics, Inc. (CNTX)

2.24 -0.08 (-3.45%) USD | NASDAQ | Feb 20, 16:00

2.23 -0.01 (-0.45%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for CNTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--
Imunon, Inc.	--